Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Awareness, knowledge and beliefs about HPV, cervical cancer and HPV vaccines among nurses in Cameroon: an exploratory study.

Wamai RG, Ayissi CA, Oduwo GO, Perlman S, Welty E, Welty T, Manga S, Onyango MA, Ogembo JG.

Int J Nurs Stud. 2013 Oct;50(10):1399-406. doi: 10.1016/j.ijnurstu.2012.12.020. Epub 2013 Feb 8.

PMID:
23395482
2.

Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review.

Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG.

PLoS One. 2014 Mar 11;9(3):e90912. doi: 10.1371/journal.pone.0090912. eCollection 2014. Review.

3.

Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.

Monsonego J, Cortes J, Greppe C, Hampl M, Joura E, Singer A.

Vaccine. 2010 Nov 29;28(51):8065-72. doi: 10.1016/j.vaccine.2010.10.017. Epub 2010 Nov 16. Review.

PMID:
20971114
4.

Initial lessons learned in HPV vaccination.

Herzog TJ, Huh WK, Downs LS, Smith JS, Monk BJ.

Gynecol Oncol. 2008 May;109(2 Suppl):S4-11. doi: 10.1016/j.ygyno.2008.01.018. Review.

PMID:
18482557
5.

Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.

Adams M, Jasani B, Fiander A.

Vaccine. 2007 Apr 20;25(16):3007-13. Epub 2007 Jan 18. Review.

PMID:
17292517
6.
7.

Efficacy and other milestones for human papillomavirus vaccine introduction.

Pagliusi SR, Teresa Aguado M.

Vaccine. 2004 Dec 16;23(5):569-78. Review.

PMID:
15630792
8.

Overcoming the barriers to HPV vaccination in high-risk populations in the US.

Downs LS Jr, Scarinci I, Einstein MH, Collins Y, Flowers L.

Gynecol Oncol. 2010 Jun;117(3):486-90. doi: 10.1016/j.ygyno.2010.02.011. Epub 2010 Mar 29. Review.

PMID:
20303156
9.

Eurogin 2010 roadmap on cervical cancer prevention.

Franceschi S, Denny L, Irwin KL, Jeronimo J, Lopalco PL, Monsonego J, Peto J, Ronco G, Sasieni P, Wheeler CM.

Int J Cancer. 2011 Jun 15;128(12):2765-74. doi: 10.1002/ijc.25915. Epub 2011 Mar 25. Review.

10.

Modifiable influences on female HPV vaccine uptake at the clinic encounter level: a literature review.

Small SL, Sampselle CM, Martyn KK, Dempsey AF.

J Am Assoc Nurse Pract. 2014 Sep;26(9):519-25. doi: 10.1002/2327-6924.12057. Epub 2013 Aug 22. Review.

11.

Current issues facing the introduction of human papillomavirus vaccine in malaysia.

Wong L, Sam I.

Malays Fam Physician. 2007 Aug 31;2(2):47-53. eCollection 2007. Review.

12.

Prevention and early detection of cervical cancer in the UK.

Foran C, Brennan A.

Br J Nurs. 2015 May 28-Jun 10;24(10):S22-4, S26, S28-9. doi: 10.12968/bjon.2015.24.Sup10.S22. Review.

PMID:
26018178
13.

Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review.

Patel H, Jeve YB, Sherman SM, Moss EL.

Sex Transm Infect. 2016 Sep;92(6):474-9. doi: 10.1136/sextrans-2015-052341. Epub 2016 Jan 20. Review.

PMID:
26792088
14.

Human papillomavirus-associated cancers: a survey on otorhinolaryngologists' knowledge and attitudes on prevention.

Odone A, Visciarelli S, Lalic T, Pezzetti F, Spagnoli F, Pasquarella C, Ferrari G, Signorelli C.

Acta Otorhinolaryngol Ital. 2015 Dec;35(6):379-85. doi: 10.14639/0392-100X-621. Review.

15.

Cancer Prevention: HPV Vaccination.

Thomas TL.

Semin Oncol Nurs. 2016 Aug;32(3):273-80. doi: 10.1016/j.soncn.2016.05.007. Epub 2016 Jul 29. Review.

Supplemental Content

Support Center